Skip to main content
Top
Published in: Cancer Causes & Control 10/2023

07-06-2023 | Original Paper

Lessons to inform interventions to reduce racial and ethnic health disparities within hematologic malignancies

Authors: Olivia M. Lin, Megan Shen, Christopher I. Li, Stephanie J. Lee

Published in: Cancer Causes & Control | Issue 10/2023

Login to get access

Abstract

Although racial and ethnic disparities in diagnosis, treatment, and survival have been well documented within the field of hematologic malignancies, very little work has focused on testing interventions that may reduce these disparities. The aim of this commentary is to review prior work in hematologic malignancies and explore new opportunities to develop disparity-reducing interventions by drawing from evidence-based strategies that have been successfully implemented in fields related to hematologic malignancies, including oncology and solid organ transplants. Relevant literature demonstrates that patient navigation and broader insurance coverage have been shown to reduce racial and ethnic disparities among patients with solid malignancies such as colorectal and breast cancer. Evidence-based strategies that might be most applicable to the field of hematologic malignancies include patient navigation and policy changes.
Literature
2.
go back to reference Fiala MA, Wildes TM (2017) Racial disparities in treatment use for multiple myeloma. Cancer 123(9):1590–1596CrossRefPubMed Fiala MA, Wildes TM (2017) Racial disparities in treatment use for multiple myeloma. Cancer 123(9):1590–1596CrossRefPubMed
3.
go back to reference Patel MI et al (2015) How do differences in treatment impact racial and ethnic disparities in acute myeloid leukemia? Cancer Epidemiol Biomarkers Prev 24(2):344–349CrossRefPubMed Patel MI et al (2015) How do differences in treatment impact racial and ethnic disparities in acute myeloid leukemia? Cancer Epidemiol Biomarkers Prev 24(2):344–349CrossRefPubMed
4.
go back to reference Hu B et al (2021) Equal access to care and nurse navigation leads to equitable outcomes for minorities with aggressive large B-cell lymphoma. Cancer 127(21):3991–3997CrossRefPubMed Hu B et al (2021) Equal access to care and nurse navigation leads to equitable outcomes for minorities with aggressive large B-cell lymphoma. Cancer 127(21):3991–3997CrossRefPubMed
5.
go back to reference Moss HA et al (2020) The affordable care act’s medicaid expansion and impact along the cancer-care continuum: a systematic review. J Natl Cancer Inst 112(8):779–791CrossRefPubMedPubMedCentral Moss HA et al (2020) The affordable care act’s medicaid expansion and impact along the cancer-care continuum: a systematic review. J Natl Cancer Inst 112(8):779–791CrossRefPubMedPubMedCentral
6.
7.
go back to reference Battaglia TA et al (2016) The impact of patient navigation on the delivery of diagnostic breast cancer care in the National Patient Navigation Research Program: a prospective meta-analysis. Breast Cancer Res Treat 158(3):523–534CrossRefPubMedPubMedCentral Battaglia TA et al (2016) The impact of patient navigation on the delivery of diagnostic breast cancer care in the National Patient Navigation Research Program: a prospective meta-analysis. Breast Cancer Res Treat 158(3):523–534CrossRefPubMedPubMedCentral
8.
go back to reference Ko NY et al (2014) Can patient navigation improve receipt of recommended breast cancer care? Evidence from the National Patient Navigation Research Program. J Clin Oncol 32(25):2758–2764CrossRefPubMedPubMedCentral Ko NY et al (2014) Can patient navigation improve receipt of recommended breast cancer care? Evidence from the National Patient Navigation Research Program. J Clin Oncol 32(25):2758–2764CrossRefPubMedPubMedCentral
9.
10.
go back to reference Patzer RE et al (2017) A randomized trial to reduce disparities in referral for transplant evaluation. J Am Soc Nephrol 28(3):935–942CrossRefPubMed Patzer RE et al (2017) A randomized trial to reduce disparities in referral for transplant evaluation. J Am Soc Nephrol 28(3):935–942CrossRefPubMed
Metadata
Title
Lessons to inform interventions to reduce racial and ethnic health disparities within hematologic malignancies
Authors
Olivia M. Lin
Megan Shen
Christopher I. Li
Stephanie J. Lee
Publication date
07-06-2023
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 10/2023
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-023-01730-x

Other articles of this Issue 10/2023

Cancer Causes & Control 10/2023 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine